Skip to main content

GOSS

Stock
Health Care
Biotechnology

Performance overview

GOSS Price
Price Chart

Forward-looking statistics

Beta
1.45
Risk
85.79%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

gossamer bio is a san diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. founded by the former receptos executive team, gossamer bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.

Company info

SectorHealth Care
IndustryBiotechnology
Employees164
Market cap$124.1M

Fundamentals

Enterprise value$224.4M
Revenue$124.6M
Revenue per employee
Profit margin-41.13%
Debt to equity-32.45

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.22
Dividend per share
Revenue per share$0.55
Avg trading volume (30 day)$4M
Avg trading volume (10 day)$7M
Put-call ratio

Macro factor sensitivity

Growth+7.6
Credit-7.0
Liquidity-1.2
Inflation+9.4
Commodities+3.6
Interest Rates-1.6

Valuation

Dividend yield0.00%
PEG Ratio-1.80
Price to sales2.26
P/E Ratio-1.80
Enterprise Value to Revenue1.80
Price to book-45.00

Upcoming events

Next earnings dayMay 16, 2025
Next dividend day
Ex. dividend day

News

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates

Gossamer Bio (GOSS) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.19 per share a year ago.

Zacks Investment Research (May 15, 2025)
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says

Oppenheimer initiated coverage on Gossamer Bio Inc GOSS, a clinical-stage biopharmaceutical company, with an Outperform rating and a price target of $9.

Benzinga (June 25, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free